Genedata Phylosopher® は治療用のターゲット ディスカバリーや各種業界向けバイオテクノロジー、システム バイオロジー研究をサポートするシステムです。1998年以来、民間企業およびアカデミック機関と協力し、継続的に開発してきたPhylosopherは、世界中の製薬およびバイオテクノロジー業界で確立されたバイオロジカル データ管理ソリューションです。
Phylosopher は、データ管理、データ解析、実験など、様々な研究にフォーカスできるモジュールで構成されています。データベース管理者は、Phylosopher の豊富なツールキットを使用してコンテンツを容易に管理し、ソフトウェア開発者は一般的なプログラミングインターフェイスを使用して既存インフラストラクチャに Phylosopher を統合することができます。
“Pfizer is pleased to gain full access to this system for antibody discovery and protein engineering.”
"Genedata Biologics is a key component of our growth plans in the immuno-oncology and next-generation ADC space."
“We undertook a thorough selection process to find the best antibody workflow platform and Genedata Biologics was the obvious choice."
"We chose Genedata Biologics as it is the only out-of-the-box platform on the market dedicated to large-molecule R&D."
"A commercial data management solution such as this has been sorely lacking in protein therapeutics."
"... Genedata Biologics has become the global industry standard for biopharma discovery organizations."
"... Genedata Biologics will help us to accelerate the discovery of the next generation of immuno-oncology therapeutics."
"... provides a modular and scalable platform supporting complex R&D workflows in a division-of-labor environment”
"... provides this functionality out-of-the-box, which saves valuable research time and money”
“Thanks to its flexible architecture, Genedata Biologics can truly support our entire discovery process..."
"... the leading workflow platform for high-throughput antibody discovery"
"We thoroughly surveyed the market and selected what we think is the leading antibody R&D workflow platform."
"... accelerates our antibody discovery programs as we develop the next generation of biologics drugs"
“It makes the highly interconnected biologics R&D processes more efficient.”
"... our central repository for mission-critical data on therapeutic candidates such as bioactivity, developability, and manufacturability"
"We are very pleased with Genedata Biologics as our central biologics registration and data management platform."
“Genedata Biologics’ flexibility allows Pfizer to configure the system to address both proprietary discovery processes as well as Pfizer-specific business processes and nomenclature.”
"... enhances Kymab’s capabilities across all our research programs"
"... provides comprehensive biologics data management functionality and the flexibility needed to support our proprietary antibody discovery processes and technology portfolio"
“One of the reasons we chose Genedata Biologics was the platform’s process coverage. We required that the full diversity of Pfizer’s large-molecule processes and technologies be supported by one integrated system.”
“... supports our scientists in a complex, multi-site environment by providing all the necessary information and tools to streamline the biologics lead generation and optimization process"
"The platform’s open architecture allows us to flexibly configure the system to work with Kymab’s proprietary workflows and technologies, including our transgenic mouse platform."
"... seamlessly integrates into an existing research informatics environment and supports the full process through automation, standardization, and integration”
“Our Biotherapeutics Research division required a central system to support the complex and interconnected workflows in our large-molecule discovery units.”
“... tracks all biologics molecules from early discovery to development”
"... our central system for registering, processing, interpreting, and sharing all our large-molecule data"
"... makes the antibody discovery and optimization process more efficient"
"... enables transparent decision-making on candidates to move forward with"
"On the Path of Personalized Medicine"
Drug Discovery News